OTC Pharmaceuticals in Asia-Pacific
- Pages: 36
- Published: September 2016
- Report Code: MLOHME7296
OTC Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Scope
Essential resource for top-line data and analysis covering the Asia-Pacific otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Reasons to buy
_x005F What was the size of the Asia-Pacific otc pharmaceuticals market by value in 2015_x005F What will be the size of the Asia-Pacific otc pharmaceuticals market in 2020
_x005F What factors are affecting the strength of competition in the Asia-Pacific otc pharmaceuticals market
_x005F How has the market performed over the last five years
_x005F Who are the top competitors in Asia-Pacific's otc pharmaceuticals market
Companies mentioned
Bayer AG
GlaxoSmithKline Plc
Johnson & Johnson
Nin Jiom Medicines Manufactory Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.